Reply: aromatase inhibition in advanced breast cancer: no conclusive evidence of efficacy differences

por Sainsbury, R
Publicado 2005

The Breast: Comprehensive Management of Benign and Malignant Disorders

por Sainsbury, R
Publicado 2004

Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy?

por Sainsbury, R
Publicado 2004

Inequalities in breast cancer care and outcome.

por Richards, M., Sainsbury, R., Kerr, D.
Publicado 1997

Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group.

por Sainsbury, R., Rider, L., Smith, A., MacAdam, A.
Publicado 1995

Surgeon workload and survival from breast cancer

por Mikeljevic, J Stefoski, Haward, R A, Johnston, C, Sainsbury, R, Forman, D
Publicado 2003

Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53 mutant Her2 and triple negative breast cancer

por Sainsbury, R, Proctor, I, Rodriguez, S, Loddo, M, Tudzarova, S, Stoeber, K, Williams, G
Publicado 2010

DNA replication licensing and cell cycle kinetics of normal and neoplastic breast

por Shetty, A, Loddo, M, Fanshawe, T, Prevost, A T, Sainsbury, R, Williams, G H, Stoeber, K
Publicado 2005

Breast cancer teams: the impact of constitution, new cancer workload, and methods of operation on their effectiveness

por Haward, R, Amir, Z, Borrill, C, Dawson, J, Scully, J, West, M, Sainsbury, R
Publicado 2003

Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer

por Loddo, M, Kingsbury, S R, Rashid, M, Proctor, I, Holt, C, Young, J, El-Sheikh, S, Falzon, M, Eward, K L, Prevost, T, Sainsbury, R, Stoeber, K, Williams, G H
Publicado 2009